The Rho-activating CNF1 toxin from pathogenic E. coli: A risk factor for human cancer development?

Infectious Agents and Cancer

Volumn 3, Issue 1, 2008, Pages

  Travaglione, Sara ^a   Fabbri, Alessia ^a   Fiorentini, Carla ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BACTERIAL TOXIN; CARCINOGEN; CYTOTOXIC NECROTIZING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

APOPTOSIS; CANCER RISK; CARCINOGENESIS; CELL INVASION; CELL MOTILITY; CELL TRANSFORMATION; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIUM CELL; HELICOBACTER PYLORI; HOST CELL; NEOPLASM; NONHUMAN; PATHOGENIC ESCHERICHIA COLI; PROTEIN EXPRESSION; REVIEW;

EID: 42449121035     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-3-4     Document Type: Review

References (82)

1. Infections as a major preventable cause of human cancer. H Kuper H-O Adami D Trichopoulos, J Int Med 2000 248 171 183 10.1046/j.1365-2796.2000.00742. x
2. How bacteria could cause cancer: one step at a time. AJ Lax W Thomas, Trends Microbiol 2002 10 293 299 10.1016/S0966-842X(02)02360-0 12088666
3. Opinion: Bacterial toxins and cancer - a case to answer? AJ Lax, Nat Rev Microbiol 2005 3 343 349 10.1038/nrmicro1130 15806096
4. Helicobacter pylori infection and the risk of gastric carcinoma. J Parsonnet GD Friedman DP Vandersteen Y Chang JH Vogelman N Orentreich RK Sibley, N Eng J Med 1991 325 16 1127 1131 1891020
5. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. AC Wotherspoon C Ortiz-Hidalgo MR Falzon PG Isaacson, Lancet 1991 338 1175 1176 10.1016/0140-6736(91)92035-Z 1682595
6. Helicobacter pylori persistence: biology and disease. MJ Blaser JC Atherton, J Clin Invest 2004 113 321 333 14755326
7. Association between hepatobiliary cancer and typhoid carrier state. JC Welton JS Marr SM Friedman, Lancet 1979 1 791 794 10.1016/S0140-6736(79)91315-1 86039
8. Cancer mortality in chronic typhoid and paratyphoid carriers. CPJ Caygill, Lancet 1994 343 83 84 10.1016/S0140-6736(94)90816-8 7903779
9. The association between typhoid carriage, typhoid infection and subsequent cancer at a number of sites. CPJ Caygill M Braddick MJ Hill RL Knowles JCM Sharp, Eur J Cancer Prev 1995 4 187 193 7767246
10. Chronic typhoid carraige and carcinoma of the gladdbladder. G Nath H Singh VK Shukla, Eur J Cancer Prev 1997 6 557 559 10.1097/00008469-199712000- 00011 9496458
11. Carcinoma of the gladdbladder-is a sequel of typhoid? VK Shukla H Singh M Pandey SK Upadhyay G Nath, Dig Dis Sci 2000 45 900 903 10.1023/A:1005564822630 10795752
12. NF-κB: linking inflammation and immunity to cancer development and progression. M Karin FR Greten, Nature Rev 2005 5 10 749 759 10.1038/nri1703 16175180
13. NF-κB in cancer: from innocent bystander to major culprit. M Karin Y Cao FR Greten ZW Li, Nature Rev Cancer 2002 2 4 301 310 10.1038/nrc780 12001991
14. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. FR Greten L Eckmann TF Greten JM Park ZW Li LJ Egan MF Kagnoff M Karin, Cell 2004 118 285 296 10.1016/j.cell.2004.07.013 15294155
15. NF-κB functions as a tumor promoter in inflammation-associated cancer. E Pikarsky RM Porat I Stein R Abramovitch A Sharon S Kasem E Gutkovich-Pyest S Uriel-Shoval E Galun Y Ben-Nerlah, Nature 2004 43 461 466 10.1038/nature02924
16. Inhibition of NF-κB in cancer cells converts inflammation-induced tumor growth mediated by TNF-α to TRAIL-mediated tumor regression. JL Luo S Maeda LC Hsu H Yagita M Karin, Cancer Cell 2004 6 297 305 10.1016/j.ccr.2004. 08.012 15380520
17. Regulation and function of IKK and IKK-related kinases. H Häcker M Karin, Sci STKE 2006 357 re13 10.1126/stke.3572006re13 17047224
18. NF-κB in solid tumors. F Pacifico A Leonardi, Biochem Pharmacol 2006 72 1142 1152 10.1016/j.bcp.2006.07.032 16956585
19. NF-κB and cancer: mechanisms and targets. M Karin, Mol Carcinogenesis 2006 45 6 355 361 10.1002/mc.20217 16673382
20. Suppression of TNF-α induced apoptosis by NF-κB. DJ Van Antwerp SJ Martin T Kafri DR Green IM Verma, Science 1996 274 787 789 10.1126/science.274.5288.787 8864120
21. Inflammation and cancer. LM Coussens Z Werb, Nature 2002 420 860 867 10.1038/nature01322 12490959
22. Oxidative DNA damage accumulation in gastric carcinogenesis. F Farinati R Cardin P Degan M Rugge F Di Mario P Bonvicini R Naccarato, Gut 1998 42 351 356 9577340
23. Helicobacter pylori causes DNA damage in gastric epithelial cells. B Obst S Wagner K Sewing W Beil, Carcinogenesis 2000 21 1111 1115 10.1093/carcin/21.6. 1111 10836997
24. Deficiency in OGG1 protects against inflammation and mutagenic effects associated with H. pylori infection in mouse. E Touati V Michel J-M Thiberge P Avé M Huerre F Bourgade A Klungland A Labigne, Helicobacter 2006 11 494 505 10.1111/j.1523-5378.2006.00442.x 16961812
25. The bacterial toxin toolkit. G Schiavo FG van der Goot, Nat Rev Mol Cell Biol 2001 2 530 537 10.1038/35080089 11433367
26. Hijacking Rho GTPases by protein toxins and apoptosis: molecular strategies of pathogenic bacteria. C Fiorentini L Falzano S Travaglione A Fabbri, Cell Death Differ 2003 10 147 152 10.1038/sj.cdd.4401151 12700642
27. New genotoxin shows diversity of bacterial attack mechanisms. AJ Lax, Trends Mol Med 2007 13 91 93 10.1016/j.molmed.2007.01.001 17234453
28. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. J-P Nougayrède S Homburg F Taieb M Boury E Brzuszkiewicz G Gottschalk C Buchrieser J Hacker U Dobrindt E Oswald, Science 313 848 851 10.1126/science.1127059 16902142
29. Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. M Hatakeyama H Higashi, Cancer Sci 2005 96 835 43 10.1111/j.1349-7006.2005.00130.x 16367902
30. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. F Bagnoli L Buti L Tompkins A Covacci MR Amieva, Proc Natl Acad Sci USA 2005 102 16339 16344 16258069 10.1073/pnas.0502598102
31. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. MJ Blaser GI Perez-Perez H Kleanthous TL Cover RM Peek PH Chyou GN Stemmermann A Nomura, Cancer Res 1995 55 2111 2115 7743510
32. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. HM Martin BJ Campbell CA Hart C Mpofu M Nayar R Singh H Englyst HF Williams JM Rhodes, Gastroenterology 2004 127 80 93 10.1053/j.gastro.2004.03. 054 15236175
33. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. A Darfeuille-Michaud J Boudeau P Bulois C Neut AL Glasser N Barnich MA Bringer A Swidsinski L Beaugerie JF Colombel, Gastroenterology 2004 127 412 421 10.1053/j.gastro.2004.04.061 15300573
34. The cytotoxic necrotizing factor 1 from Escherichia coli. P Boquet C Fiorentini, Bacterial Protein toxins. Handbook of Experimental Pharmacology Berlin: Springer, Aktories K, Just I, 2000 145 361 379
35. Characterization of the roles of hemolysin and other toxins in enteropathy caused by alpha-hemolytic Escherichia coli linked to human diarrhea. SJ Elliott S Srinivas MJ Albert K Alam RM Robins-Browne ST Gunzburg BJ Mee BJ Chang, Infect Immun 1998 66 2040 2051 9573087
36. Characterization of Escherichia coli strains from cases of childhood diarrhea in provincial southwestern Nigeria. IN Okeke A Lamikanra H Steinruck JB Kaper, J Clin Microbiol 2000 38 7 12 10618054
37. Virulence properties of Escherichia coli faecal strains isolated in Poland from healthy children and strains belonging to serogroups O18, O26, O44, O86, O126 and O127 isolated from children with diarrhoea. J Paciorek, J Med Microbiol 2002 51 548 556 12132770
38. Necrotoxic Escherichia coli (NTEC): two emerging categories of human and animal pathogens. J De Rycke A Milon E Oswald, Vet Res 1999 30 221 233 10367356
39. Frequency of Escherichia coli strains producing the cytotoxic necrotizing factor (CNF1) in nosocomial urinary tract infections. L Landraud M Gauthier T Fosse P Boquet, Lett Appl Microbiol 2000 30 213 216 10.1046/j.1472-765x.2000. 00698.x 10747253
40. The cytotoxic necrotizing factor 1 (CNF1) from Escherichia coli. P Boquet, Toxicon 2001 39 1673 1680 10.1016/S0041-0101(01)00154-4 11595630
41. Comparative evaluation of three tests for the detection of Escherichia coli cytotoxic necrotizing factors (CNF1 and CNF2) using filtrates of cultures treated with mitomycin C. J Blanco M Blanco EA Gonzalez MP Alonso JI Garabal, FEMS Microbiol Lett 1990 57 311 316 10.1111/j.1574-6968.1990.tb04250.x 2120109
42. A uropathogenicity island contributes to the pathogenicity of Escherichia coli strains that cause neonatal meningitis. V Houdouin S Bonacorsi N Brahimi O Clermont X Nassif E Bingen, Infect Immun 2002 70 5865 5869 12228319 10.1128/IAI.70.10.5865-5869.2002
43. Partial purification and characterization of an Escherichia coli toxic factor that induces morphological cell alterations. A Caprioli V Falbo LG Roda FM Ruggeri C Zona, Infect Immun 1983 39 1300 1306 6341235
44. A cell division-active protein from E. coli. A Caprioli G Donelli V Falbo R Possenti LG Roda G Roscetti FM Ruggeri, Biochem Biophys Res Commun 1984 118 587 593 10.1016/0006-291X(84)91343-3 6367741
45. Molecular localization of the Escherichia coli cytotoxic necrotizing factor CNF1 cell-binding and catalytic domains. E Lemichez G Flatau M Bruzzone P Boquet M Gauthier, Mol Microbiol 1997 24 1061 1070 10.1046/j.1365-2958.1997. 4151781.x 9220012
46. The 5' region of cnf1 harbours a translational regulatory mechanism for CNF1 synthesis and encodes the cell-binding domain of the toxin. A Fabbri M Gauthier P Boquet, Mol Microbiol 1999 33 108 118 10.1046/j.1365-2958.1999.01453. x 10411728
47. The p21 Rho-activating toxin cytotoxic necrotizing factor 1 is endocytosed by a clathrin-independent mechanism and enters the cytosol by an acidic-dependent membrane translocation step. S Contamin A Galmiche A Doye G Flatau A Benmerah P Boquet, Mol Biol Cell 2000 11 1775 1787 10793151
48. 67-kDa laminin receptor promotes internalization of cytotoxic necrotizing factor 1-expressing Escherichia coli K1 into human brain microvascular endothelial cells. KJ Kim JW Chung KS Kim, J Biol Chem 2005 280 1360 1368 10.1074/jbc.M410176200 15516338
49. Mutation of specific acidic residues of the CNF1 T domain into lysine alters cell membrane translocation of the toxin. S Pei A Doye P Boquet, Mol Microbiol 2001 41 1237 1247 10.1046/j.1365-2958.2001.02596.x 11580831
50. Rho GTPases in cell biology. S Etienne-Manneville A Hall, Nature 2002 420 629 635 10.1038/nature01148 12478284
51. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. G Flatau E Lemichez M Gauthier P Chardin S Paris C Fiorentini P Boquet, J Biol Chem 1997 272 19532 19537 10.1074/jbc.272.31.19532 9235957
52. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. G Schmidt P Sher M Wilm J Selzer M Mann K Aktories, Nature 1997 387 725 729 10.1038/42735 9192900
53. Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: activation of the C-Jun N-terminal kinase in HeLa cells. M Lerm J Selzer A Hoffmeyer UR Rapp K Aktories G Schmidt, Infect Immun 1999 67 496 503 9916051
54. Crystal structure of a small G protein in complex with the GTPase-activating protein rhoGAP. K Rittinger PA Walker JF Eccleston K Nurmahomed D Owen E Laue SJ Gamblin SJ Smerdon, Nature 1997 388 693 697 10.1038/41805 9262406
55. Ras oncogenes in human cancer: a review. JL Bos, Cancer Res 1989 49 4682 4689 2547513
56. Cytoskeletal changes induced in HEp-2 cells by the cytotoxic necrotizing factor of Escherichia coli. C Fiorentini G Arancia A Caprioli V Falbo FM Ruggeri G Donelli, Toxicon 1988 26 1047 1056 10.1016/0041-0101(88)90203-6 3072687
57. Induction of phagocytic behaviour in human epithelial cells by Escherichia coli cytotoxic necrotizing factor type 1. L Falzano C Fiorentini G Donelli E Michel C Kocks P Cossart L Cabanié E Oswald P Boquet, Mol Microbiol 1993 9 1247 1254 10.1111/j.1365-2958.1993.tb01254.x 7934938
58. Activation of rho GTPases by cytotoxic necrotizing factor 1 induces macropinocytosis and scavenging activity in epithelial cells. C Fiorentini L Falzano A Fabbri A Stringaro M Logozzi S Travaglione S Contamin G Arancia W Malorni S Fais, Mol Biol Cell 2001 12 2061 2073 11452003
59. CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion. A Doye A Mettouchi G Bossis R Clement C Buisson-Touati G Flatau L Gagnoux M Piechaczyk P Boquet E Lemichez, Cell 2002 111 553 564 10.1016/S0092-8674(02)01132-7 12437928
60. A Salmonella protein antagonizes Rac1 and Cdc42 to mediate host-cell recovery after bacterial invasion. Y Fu JE Galàn, Nature 1999 401 293 297 10.1038/45829 10499590
61. Triggered phagocytosis by Salmonella : bacterial molecular mimicry of RhoGTPase activation/deactivation. MC Schlumberger WD Hardt, Curr Top Microbiol Immunol 2005 291 29 42 15981458
62. Rho proteins and cancer. AJ Ridley, Breast Cancer res Treat 2004 84 13 19 10.1023/B:BREA.0000018423.47497.c6 14999150
63. Characterization of RhoC expression in benign and malignant breast disease. CG Kleer KL van Golen Y Zhang ZF Wu MA Rubin SD Merajver, Am J Pathol 2002 160 579 584 11839578
64. Inflammation and cancer: the link grows stronger. J Marx, Cancer Res 2004 306 5698 966 968 15528423
65. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. S Ghosh MJ May EB Kopp, Annu Rev Immunol 1998 16 225 260 10.1146/annurev.immunol.16.1.225 9597130
66. Rac GTPase instructs Nuclear Factor-kB activating by conveying the SCF complex and IkB-alpha to the ruffling membranes. L Boyer S Travaglione L Falzano NC Gauthier MR Popoff E Lemichez C Fiorentini A Fabbri, Mol Biol Cell 2004 15 1124 1133 14668491 10.1091/mbc.E03-05-0301
67. Rho-dependent cell spreading activated by E. coli cytotoxic necrotizing factor 1 hinders apoptosis in epithelial cells. C Fiorentini P Matarrese E Straface L Falzano G Donelli P Boquet W Malorni, Cell Death Differ 1998 5 720 728 10.1038/sj.cdd.4400412 10200530
68. Toxin-induced activation of Rho GTP-binding protein increases Bcl-2 expression and influences mitochondrial homeostasis. C Fiorentini P Matarrese E Straface L Falzano A Fabbri G Donelli A Cossarizza P Boquet W Malorni, Exp Cell Res 1998 242 341 350 10.1006/excr.1998.4057 9665831
69. Cytotoxic necrotizing factor 1 prevents apoptosis via the Akt/IkappaB kinase pathway: role of nuclear factor-kappaB and Bcl-2. A Giamboi Miraglia S Travaglione S Meschini L Falzano P Matarrese MG Quaranta M Viora C Fiorentini A Fabbri, Mol Biol Cell 2007 18 2735 2744 17507655 10.1091/mbc.E06-10-0910
70. Effect of bcl-2 overexpression on mitochondrial structure and function. AJ Kowaltowski RG Cosso CB Campos G Fiskum, J Biol Chem 2002 277 42802 42807 10.1074/jbc.M207765200 12207028
71. The many shape of mitochondrial death. GM Cereghetti L Scorrano, Oncogene 2006 25 4717 4724 10.1038/sj.onc.1209605 16892085
72. Role for CED-9 and Egl-1 as regulators of mitochondrial fission and fusion dynamics. P Delivani C Adrain RC Taylor PJ Duriez SJ Martin, Mol Cell 2006 21 761 773 10.1016/j.molcel.2006.01.034 16543146
73. Mitochondria and cancer: is there a morphological connection? E Alirol JC Martinou, Oncogene 2006 25 4706 4716 10.1038/sj.onc.1209600 16892084
74. Cytotoxic necrotizing factor 1 enhances reactive oxygen species-dependent transcription and secretion of proinflammatory cytokines in human uroepithelial cells. L Falzano MG Quaranta S Travaglione P Filippini A Fabbri M Viora G Donelli C Fiorentini, Infect Immun 2003 71 4178 4181 12819113 10.1128/IAI.71.7.4178-4181.2003
75. Activation and proteasomal degradation of Rho GTPases by cytotoxic necrotizing factor-1 elicit a controlled inflammatory response. P Munro G Flatau A Doye L Boyer O Oregioni JL Mege L Landraud E Lemichez, J Biol Chem 2004 279 35849 35857 10.1074/jbc.M401580200 15152002
76. Cytotoxic necrotizing factor from Escherichia coli induces RhoA-dependent expression of the cyclooxygenase-2 gene. W Thomas ZK Ascott D Harmey LW Slice E Rozengurt AJ Lax, Infect Immun 2001 69 6839 6845 11598057 10.1128/IAI.69.11. 6839-6845.2001
77. Cyclooxygenase-2 and gastrointestinal cancer. JR Mann RN Dubois, Cancer J 2004 10 145 152 15285921
78. Cyclooxygenase-2: a potential target in breast cancer. D Wang RN Dubois, Semin Oncol 2004 31 64 73 10.1053/j.seminoncol.2004.01.008 15052544
79. Cyclooxygenase 2: from inflammation to carcinogenesis. A Ristimaki, Novartis Found Symp 2004 256 215 221 15027493
80. Is the Rac GTPase-activating toxin CNF1 a smart hijacker of host cell fate? W Malorni C Fiorentini, FASEB J 2006 20 606 609 10.1096/fj.05-4706hyp 16581968
81. Exploiting cell death pathways by an E. coli cytotoxin: autophagy as a double-edged sword for the host. C Fiorentini W Malorni, Autophagy 2006 2 310 311 16921260
82. Escherichia coli cytotoxic necrotizing factor 1 blocks cell cycle G2/M transition in uroepithelial cells. L Falzano P Filippini S Travaglione AG Miraglia A Fabbri C Fiorentini, Infect Immun 2006 74 3765 3772 16790748 10.1128/IAI.01413-05